PhRMA filed a complaint in the U.S. District Court for the District of Maryland asserting that the 340B Drug Pricing Program: Administrative Dispute Resolution Regulation is arbitrary and capricious, not the product of reasoned decision-making and unconstitutional.

Download the complaint summary and full complaint here.